Chemotherapy and Oral Health

Acute Oral Effects During Chemotherapy

Most patients experience some oral effects during active chemotherapy, ranging from mild to severe.

Oral mucositis: Inflammation, ulceration, and sometimes severe pain in the lining of the mouth. Most common with certain regimens (5-FU, methotrexate, doxorubicin, conditioning regimens for transplant) but possible with many. Usually appears 5 to 14 days into a cycle and resolves in 2 to 4 weeks. In severe cases, can affect eating, drinking, and quality of life significantly.

Taste changes: Diminished, distorted, or absent taste during treatment. Often described as metallic. Most patients see significant recovery after treatment ends, though some have persistent changes.

Increased infection risk: Reduced white blood cell counts during chemotherapy increase risk of oral infections. Fungal infections (oral thrush) are common. Bacterial infections from previously stable dental issues can become acute.

Dry mouth: Less severe than radiation-induced dryness, but still significant for many patients during and sometimes after treatment.

Bleeding gums and oral mucosa: Patients with low platelets are at risk for bleeding from the gums, particularly with brushing or flossing.

Increased sensitivity: Teeth and tissues may be more sensitive to hot, cold, sweet, or acidic foods.

Lip and corner-of-mouth cracks: Angular cheilitis can develop, particularly with dry mouth or fungal infection.

Managing Oral Effects During Treatment

Patients in active chemotherapy should:

Continue oral hygiene gently. Soft toothbrush, gentle technique. Stop if bleeding becomes problematic without consultation.

Use bland mouth rinses. Salt and baking soda water, or prescribed rinses for mucositis. Avoid alcohol-containing mouthwashes.

Treat fungal infections promptly. Oral thrush is common during chemotherapy and treatable with antifungal medications.

Address dry mouth. Frequent sips of water, saliva substitutes, sugar-free gum or lozenges (if not contraindicated by treatment).

Avoid trauma. Hot, sharp, or hard foods can injure fragile mucosa. Soft, lukewarm, gentle foods are friendlier.

Avoid elective dental work during active chemotherapy. Routine cleanings and elective procedures should generally be deferred. Urgent dental issues need coordinated management with the oncology team.

Maintain communication with your team. Oral problems should be reported to your oncology team promptly. Some problems require dose adjustment or supportive intervention.

Long-Term Effects of Chemotherapy

Beyond the acute effects, chemotherapy can have longer-term consequences:

Persistent taste changes. Most resolve, but some persist for months or years.

Persistent dry mouth. Less common with chemotherapy alone than with radiation, but still possible.

Weakened tooth structure. Some patients, particularly those who received intensive chemotherapy as children or adolescents, have permanent effects on enamel quality and tooth development.

Increased decay risk. From combinations of dry mouth, dietary changes during treatment, and altered oral microbiology.

Risk from bone-modifying drugs. Many cancer patients also receive bisphosphonates (Zometa, Reclast, Aredia) or denosumab (Xgeva, Prolia) for bone metastases or osteoporosis prevention. These medications carry their own risk for medication-related osteonecrosis of the jaw (MRONJ/BRONJ) that follows patients long after chemotherapy ends.

Bone-Modifying Drugs: A Critical Subtopic

If you have received bisphosphonates, denosumab, or related drugs at any point, even years ago, this affects how dental care should be approached. Risks include:

MRONJ/BRONJ. Bone death in the jaw, often triggered by extractions or other oral procedures, sometimes occurring spontaneously. Risk varies by drug, dose, duration, and route (IV bisphosphonates carry higher risk than oral; high-dose oncologic regimens carry higher risk than osteoporosis-dose regimens).

Persistent risk after stopping the drug. Bisphosphonates remain in bone for years after the last dose, and risk does not immediately resolve when treatment ends.

For survivors with this history, a dental oncologist should be involved before any extraction, implant, or oral surgery. See dental care after chemotherapy.

Pediatric Considerations

Children and adolescents who receive chemotherapy may have specific dental developmental effects:

• Abnormal tooth development including small or missing teeth
• Root abnormalities in teeth that develop during chemotherapy
• Enamel defects that affect appearance and function
• Eruption issues for permanent teeth
• Increased lifetime decay risk from these structural issues

Pediatric survivors entering adulthood often benefit from specialized dental evaluation and planning for restorations. See dental care after stem cell or bone marrow transplant for related considerations.

Re-Establishing Dental Care After Treatment

Once chemotherapy is complete and recovery is stable, re-establishing dental care should include:

Comprehensive evaluation. A thorough exam to identify decay, gum issues, or other problems that need attention.

Risk-based maintenance scheduling. Often every 3 to 4 months for the first year or two after treatment, then individualized.

Restoration of damaged teeth. Crowns, fillings, or more comprehensive restoration as needed.

Decay prevention. Custom fluoride trays, fluoride toothpaste, dietary counseling.

Implant planning when needed. Implants are usually possible with appropriate evaluation.

Coordination with your oncology team for ongoing care.

When to Seek Specialized Dental Oncology Care

For chemotherapy survivors, specialized care is most relevant when:

• You also received head and neck radiation
• You received bisphosphonates, denosumab, or anti-angiogenic drugs
• You had a stem cell or bone marrow transplant
• You are about to start or restart chemotherapy and need pre-treatment dental clearance
• You have unresolved oral issues from treatment
• You need substantial dental restoration